Physician profile
Jinhan Chi
NPI 1952383275
$2,209.03
in general payments reported to CMS, 2019-2025
18 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $295 · 2021: $880 · 2022: $217 · 2023: $163 · 2024: $175 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $499.16 | 2019-2023 | Linzess, Creon |
| Novo Nordisk INC | $491.50 | 2021 | |
| Amarin Pharma, INC. | $339.45 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $159.74 | 2023-2024 | Ztlido |
| Nestle Healthcare Nutrition INC. | $159.02 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.29 | 2022 | |
| Amgen INC. | $100.70 | 2019-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $67.89 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $52.88 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $31.19 | 2024 | Farxiga |
| Glaxosmithkline, LLC. | $29.68 | 2020-2025 | Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $29.61 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $29.45 | 2021 | |
| Sanofi Pasteur INC. | $27.55 | 2019-2020 | |
| Nevro Corp. | $23.28 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $20.26 | 2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $15.62 | 2023 | |
| Allergan, INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jinhan Chi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.